I wonder if this is going to be a $100 drug like lamivudine or a $100,000 drug like some other specialized antivirals.
It’s a ‘new’ drug and probably still has 7 years left on patent.
So I’ll go with $100,000 per dose Alex.
Meanwhile, the Africans will just use lamivudine. Till WHO finds a way to shut down their shipments.
I guess if it was being developed to treat adenovirus infections it must be projected to be quite inexpensive.